Clinical Trial Update: EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma [Phase 1]

View source ↗

Summary

This document reports the termination of a Phase 1 trial evaluating EMD 121974 in patients with HIV-related Kaposi's sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• EMD 121974

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Sarcoma | Phase 1 | Status: TERMINATED